This inventor holds 1 USPTO granted patent and 1 published patent application and 16 EPO patents. Top assignee: Krka. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Inventor Vesna Kroselj: Innovations in Pharmaceutical Composition
Introduction: Vesna Kroselj, a notable inventor from Sentjernej, Slovenia, has made significant strides in the field of pharmaceutical technology. With a focus on improving the efficacy of medicaments, her contributions have important implications for treating conditions such as atherosclerosis.
Latest Patents: Kroselj holds a patent for a pharmaceutical composition comprising simvastatin and ezetimibe. This innovative formulation is designed to reduce the contact of the composition with oxygen, thereby enhancing its stability and effectiveness. The novel dosage forms aim to provide effective treatments while taking into account the environmental factors that can affect drug efficacy.
Career Highlights: As an integral member of Krka, a leading pharmaceutical company, Vesna Kroselj has been actively involved in developing advanced pharmaceutical solutions. Her groundbreaking work not only adds value to the company but also contributes significantly to the healthcare field.
Collaborations: Collaborating with esteemed colleagues Renata Lakse and Rebeka Toporisic, Kroselj has engaged in joint endeavors that foster innovation and research within the company. Their combined expertise highlights the importance of teamwork in achieving successful outcomes in pharmaceutical development.
Conclusion: Vesna Kroselj's contributions to pharmaceutical innovation underscore the potential of novel compositions in improving health outcomes. Her work at Krka, along with the collaboration with her coworkers, demonstrates how dedicated inventors can lead advancements in the medical field, paving the way for better treatment options.